ImmunityBio (IBRX) FCF Margin (2014 - 2026)
ImmunityBio (IBRX) posted FCF Margin of -136.64% for Q2 2026, up 169.23 percentage points from -305.87% a year earlier and up 37.94 percentage points from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) FCF Margin (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, FCF Margin at ImmunityBio was -173.78%, up 456.36 percentage points year-over-year; for FY2025, it came in at -272.56%, up 2427.50 percentage points from FY2024.
- Annual FCF Margin has increased for three consecutive years, with a five-year change of +28387.44 percentage points (FY2020 to FY2025).
- In prior years, ImmunityBio's FCF Margin was -2700.06% in FY2024 (+61181.13 pp), -63881.19% in FY2023 (+109315.06 pp), -173196.25% in FY2022 (-140221.73 pp) and -32974.52% in FY2021 (-4314.52 pp).
- The Q2 2026 figure stands as the highest quarterly FCF Margin since Q1 2014.
- On a year-over-year basis, FCF Margin has increased in each of the last nine quarters, with an average year-over-year change of +60213.47 percentage points over the last eight quarters.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q1 2023, with a gain of 704789.44 percentage points; the weakest was Q1 2022, with a drop of 681951.44 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was -174.58% (Q1 2026), -186.08% (Q4 2025) and -217.37% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | ImmunityBio | 8.97 Bn | 7.74 Bn | 50.94 Mn | -136.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -136.64% |
| Mar 31, 2026 | -174.58% |
| Dec 31, 2025 | -186.08% |
| Sep 30, 2025 | -217.37% |
| Jun 30, 2025 | -305.87% |
| Mar 31, 2025 | -526.89% |
| Dec 31, 2024 | -1,155.39% |
| Sep 30, 2024 | -1,663.20% |
| Jun 30, 2024 | -9,653.39% |
| Mar 31, 2024 | -270,607.50% |
| Dec 31, 2023 | -88,651.80% |
| Sep 30, 2023 | -113,509.76% |
| Jun 30, 2023 | -215,363.41% |
| Mar 31, 2023 | -25,760.56% |
| Dec 31, 2022 | -150,216.44% |
| Sep 30, 2022 | -81,809.32% |
| Jun 30, 2022 | -306,288.57% |
| Mar 31, 2022 | -730,550.00% |
| Dec 31, 2021 | -21,036.41% |
| Sep 30, 2021 | -122,345.45% |
API Access
ImmunityBio FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();